New daily pill MPB-1734 enters human trials for Hard-to-Treat cancers
Disease control
Recruiting now
This early-phase trial is testing a new oral drug called MPB-1734 in adults with advanced solid tumors that have not responded to standard treatments. The study has two parts: first, finding the safest dose, and second, testing that dose in specific tumor types. Researchers will …
Phase: PHASE1, PHASE2 • Sponsor: MegaPro Biomedical Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC